The plaintiffs represent some of the leading manufacturers of the life-saving drug, and as such are responsible for more than 90% of global insulin sales. UnitedHealth Group Inc’s Optum unit, CVS Health Corp’s CVS Caremark and Cigna Corp’s Express Scripts, which are all pharmacy benefits managers, were also named in the suit.